Bausch + Lomb's U.S. shares tracking record gain after Q4 beat

Feb 21, 2024 · ** U.S.-listed shares of Canada's Bausch + Lomb Corp BLCO up 10.6% at $16.14 on Weds, 6-week high, after eye care firm's results top expectations ** BLCO on course for …

6%
OFF

Bausch + Lomb's U.S. Shares Tracking Record Gain After Q4 Beat

2 weeks from now

Feb 21, 2024 · ** U.S.-listed shares of Canada's Bausch + Lomb Corp BLCO up 10.6% at $16.14 on Weds, 6-week high, after eye care firm's results top expectations ** BLCO on course for …

tradingview.com

9%
OFF

Bausch & Lomb’s Stock Soars 9% After Earnings Beat

2 weeks from now

Feb 21, 2024 · Bausch & Lomb Corp.’s stock soared 10% early Wednesday after the eye-care company reported adjusted fourth-quarter profit that topped estimates and offered upbeat …

marketwatch.com

$0.13
OFF

Bausch + Lomb Posts Top-line Beat, Raises Full-year Outlook

2 weeks from now

Oct 30, 2024 · Bausch + Lomb posts top-line beat, raises full-year outlook ... Adjusted earnings per share came in at $0.13, missing analyst estimates of $0.16. ... AI-powered stock picks with …

investing.com

$0.15
OFF

Bausch + Lomb Announces Fourth-Quarter And Full-Year 2023 …

2 weeks from now

Feb 21, 2024 · GAAP Earnings Per Share (“EPS”) Basic and Diluted attributable to Bausch + Lomb Corporation for the fourth quarter of 2023 was ($0.15), as compared to $0.00 for the …

bausch.com

11%
OFF

Bausch + Lomb Stock Jumps After Better-Than-Expected Earnings …

2 weeks from now

Bausch + Lomb Corp. shares jumped more than 11% Wednesday after the eye-care company posted better-than-expected results and guidance, boosted by sales of its pharmaceutical …

msn.com

14%
OFF

Bausch + Lomb: Q4 Earnings Snapshot - Yahoo Finance

2 weeks from now

Feb 21, 2024 · Bausch + Lomb expects full-year revenue in the range of $4.6 billion to $4.7 billion. Bausch + Lomb shares have fallen 14% since the beginning of the year. The stock has fallen …

yahoo.com

$1
OFF

Bausch + Lomb Beats Q4 Profit And Revenue Estimates

2 weeks from now

Bausch + Lomb Corp. BLCO said Wednesday it had a loss of $1 million, or breakeven on a per-share basis, for the fourth quarter, after earnings of $51 million, or 15 cents a share, in the year ...

marketwatch.com

51%
OFF

What's In The Cards For Bausch Health (BHC) Q4 Earnings?

2 weeks from now

Feb 21, 2022 · Bausch’s earnings track record has been excellent so far. The company beat earnings expectations in each of the last four quarters, the average surprise being 9.51%.

zacks.com

14%
OFF

Bausch Health's (BHC) Q4 Earnings & Sales Beat, Shares Up

2 weeks from now

Feb 25, 2023 · Shares of Bausch Health Companies Inc.BHC were up 14% in response to fourth-quarter 2022 results.. The company’s adjusted earnings per share of $1.02, which beat the …

nasdaq.com

14%
OFF

Bausch Health's (BHC) Q4 Earnings & Sales Beat, Shares Up

2 weeks from now

Feb 25, 2023 · Shares of Bausch Health Companies Inc.BHC were up 14% in response to fourth-quarter 2022 results. The company’s adjusted earnings per share of $1.02, which beat the …

yahoo.com

FAQs about Bausch + Lomb's U.S. shares tracking record gain after Q4 beat Coupon?

How much did Bausch & Lomb Corporation earn in Q4 2023?

GAAP Earnings Per Share (“EPS”) Basic and Diluted attributable to Bausch + Lomb Corporation for the fourth quarter of 2023 was ($0.15), as compared to $0.00 for the fourth quarter of 2022. ...

How did Bausch & Lomb perform in the fourth quarter?

A big jump in pharmaceutical sales helped eye-care products manufacturer Bausch + Lomb beat profit and sales estimates for the fourth quarter. Bausch + Lomb also delivered full-year 2024 guidance that was better than expected. CEO Brent Saunders said the 2023 results, especially in the fourth quarter, "set the tone" for this year. ...

Why did Bausch & Lomb shares rise 11% Wednesday?

Bausch + Lomb shares rose more than 11% Wednesday after the positive earnings news. Bausch + Lomb Corp. ( BLCO) shares jumped more than 11% Wednesday after the eye-care company posted better-than-expected results and guidance, boosted by sales of its pharmaceutical products. ...

How did Bausch + Lomb perform in 2023?

“Revenue growth in 2023, and in the fourth quarter in particular, exceeded our expectations and set the tone for 2024,” said Brent Saunders, chairman and CEO, Bausch + Lomb. “Double-digit growth is always impressive, but even more so when you consider how we got there. Our quality of growth is what helps set us apart from others.” ...

What will Bausch & Lomb's full-year revenue look like?

Bausch + Lomb predicts full-year revenue will be in the range of $4.6 billion to $4.7 billion, higher than what analysts were expecting . Shares of Bausch + Lomb had fallen to an all-time low earlier this month, and even with Wednesday's surge to $16.26 at 3:06 p.m. ET, they’re still down about 14% year over year. ...

Why did Bausch & Lomb stock pop premarket Wednesday?

Bausch & Lomb’s stock popped premarket Wednesday after the vision care company beat profit estimates for the fourth quarter. This feature is powered by text-to-speech technology. Want to see it on more articles? ...